Global RSV mRNA Vaccine Market Growth 2025-2031

July 2025 | 106 pages | ID: R6A15DA254D8EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global RSV mRNA Vaccine market size is predicted to grow from US$ 528 million in 2025 to US$ 728 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

RSV mRNA Vaccine is an mRNA vaccine targeting Respiratory Syncytial Virus (RSV). RSV is a common respiratory virus that can cause cold-like symptoms and lower respiratory tract infections, particularly in infants, toddlers, and older adults. The RSV mRNA Vaccine utilizes mRNA technology to introduce mRNA sequences encoding RSV virus antigens into human cells, thereby inducing an immune response against RSV. This vaccine offers advantages such as high efficiency, safety, and ease of production, providing a new solution for preventing RSV infections. By administering the RSV mRNA Vaccine, the risk of RSV infection can be effectively reduced, related symptoms can be alleviated, and complications caused by RSV infections can be decreased.

United States market for RSV mRNA Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for RSV mRNA Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for RSV mRNA Vaccine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key RSV mRNA Vaccine players cover Abogen Bio, Innorna, Starna Therapeutics, Hualan Biological Engineering, SINOVAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “RSV mRNA Vaccine Industry Forecast” looks at past sales and reviews total world RSV mRNA Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected RSV mRNA Vaccine sales for 2025 through 2031. With RSV mRNA Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RSV mRNA Vaccine industry.

This Insight Report provides a comprehensive analysis of the global RSV mRNA Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RSV mRNA Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RSV mRNA Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RSV mRNA Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RSV mRNA Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of RSV mRNA Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Base Modification Technology
  • m1? Modification Technology
Segmentation by Application:
  • Hospital
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Abogen Bio
  • Innorna
  • Starna Therapeutics
  • Hualan Biological Engineering
  • SINOVAC
  • Moderna
  • GSK
  • Pfizer
  • Sanofi
  • Nanoribo
  • Immorna
  • AIM Vaccine
  • Shijiazhuang Pharma Group
Key Questions Addressed in this Report

What is the 10-year outlook for the global RSV mRNA Vaccine market?
What factors are driving RSV mRNA Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RSV mRNA Vaccine market opportunities vary by end market size?
How does RSV mRNA Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RSV mRNA Vaccine Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for RSV mRNA Vaccine by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for RSV mRNA Vaccine by Country/Region, 2020, 2024 & 2031
2.2 RSV mRNA Vaccine Segment by Type
  2.2.1 Base Modification Technology
  2.2.2 m1? Modification Technology
2.3 RSV mRNA Vaccine Sales by Type
  2.3.1 Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
  2.3.2 Global RSV mRNA Vaccine Revenue and Market Share by Type (2020-2025)
  2.3.3 Global RSV mRNA Vaccine Sale Price by Type (2020-2025)
2.4 RSV mRNA Vaccine Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Others
2.5 RSV mRNA Vaccine Sales by Application
  2.5.1 Global RSV mRNA Vaccine Sale Market Share by Application (2020-2025)
  2.5.2 Global RSV mRNA Vaccine Revenue and Market Share by Application (2020-2025)
  2.5.3 Global RSV mRNA Vaccine Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global RSV mRNA Vaccine Breakdown Data by Company
  3.1.1 Global RSV mRNA Vaccine Annual Sales by Company (2020-2025)
  3.1.2 Global RSV mRNA Vaccine Sales Market Share by Company (2020-2025)
3.2 Global RSV mRNA Vaccine Annual Revenue by Company (2020-2025)
  3.2.1 Global RSV mRNA Vaccine Revenue by Company (2020-2025)
  3.2.2 Global RSV mRNA Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global RSV mRNA Vaccine Sale Price by Company
3.4 Key Manufacturers RSV mRNA Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers RSV mRNA Vaccine Product Location Distribution
  3.4.2 Players RSV mRNA Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR RSV MRNA VACCINE BY GEOGRAPHIC REGION

4.1 World Historic RSV mRNA Vaccine Market Size by Geographic Region (2020-2025)
  4.1.1 Global RSV mRNA Vaccine Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global RSV mRNA Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic RSV mRNA Vaccine Market Size by Country/Region (2020-2025)
  4.2.1 Global RSV mRNA Vaccine Annual Sales by Country/Region (2020-2025)
  4.2.2 Global RSV mRNA Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas RSV mRNA Vaccine Sales Growth
4.4 APAC RSV mRNA Vaccine Sales Growth
4.5 Europe RSV mRNA Vaccine Sales Growth
4.6 Middle East & Africa RSV mRNA Vaccine Sales Growth

5 AMERICAS

5.1 Americas RSV mRNA Vaccine Sales by Country
  5.1.1 Americas RSV mRNA Vaccine Sales by Country (2020-2025)
  5.1.2 Americas RSV mRNA Vaccine Revenue by Country (2020-2025)
5.2 Americas RSV mRNA Vaccine Sales by Type (2020-2025)
5.3 Americas RSV mRNA Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RSV mRNA Vaccine Sales by Region
  6.1.1 APAC RSV mRNA Vaccine Sales by Region (2020-2025)
  6.1.2 APAC RSV mRNA Vaccine Revenue by Region (2020-2025)
6.2 APAC RSV mRNA Vaccine Sales by Type (2020-2025)
6.3 APAC RSV mRNA Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe RSV mRNA Vaccine by Country
  7.1.1 Europe RSV mRNA Vaccine Sales by Country (2020-2025)
  7.1.2 Europe RSV mRNA Vaccine Revenue by Country (2020-2025)
7.2 Europe RSV mRNA Vaccine Sales by Type (2020-2025)
7.3 Europe RSV mRNA Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RSV mRNA Vaccine by Country
  8.1.1 Middle East & Africa RSV mRNA Vaccine Sales by Country (2020-2025)
  8.1.2 Middle East & Africa RSV mRNA Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa RSV mRNA Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa RSV mRNA Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RSV mRNA Vaccine
10.3 Manufacturing Process Analysis of RSV mRNA Vaccine
10.4 Industry Chain Structure of RSV mRNA Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 RSV mRNA Vaccine Distributors
11.3 RSV mRNA Vaccine Customer

12 WORLD FORECAST REVIEW FOR RSV MRNA VACCINE BY GEOGRAPHIC REGION

12.1 Global RSV mRNA Vaccine Market Size Forecast by Region
  12.1.1 Global RSV mRNA Vaccine Forecast by Region (2026-2031)
  12.1.2 Global RSV mRNA Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global RSV mRNA Vaccine Forecast by Type (2026-2031)
12.7 Global RSV mRNA Vaccine Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Abogen Bio
  13.1.1 Abogen Bio Company Information
  13.1.2 Abogen Bio RSV mRNA Vaccine Product Portfolios and Specifications
  13.1.3 Abogen Bio RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Abogen Bio Main Business Overview
  13.1.5 Abogen Bio Latest Developments
13.2 Innorna
  13.2.1 Innorna Company Information
  13.2.2 Innorna RSV mRNA Vaccine Product Portfolios and Specifications
  13.2.3 Innorna RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Innorna Main Business Overview
  13.2.5 Innorna Latest Developments
13.3 Starna Therapeutics
  13.3.1 Starna Therapeutics Company Information
  13.3.2 Starna Therapeutics RSV mRNA Vaccine Product Portfolios and Specifications
  13.3.3 Starna Therapeutics RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Starna Therapeutics Main Business Overview
  13.3.5 Starna Therapeutics Latest Developments
13.4 Hualan Biological Engineering
  13.4.1 Hualan Biological Engineering Company Information
  13.4.2 Hualan Biological Engineering RSV mRNA Vaccine Product Portfolios and Specifications
  13.4.3 Hualan Biological Engineering RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Hualan Biological Engineering Main Business Overview
  13.4.5 Hualan Biological Engineering Latest Developments
13.5 SINOVAC
  13.5.1 SINOVAC Company Information
  13.5.2 SINOVAC RSV mRNA Vaccine Product Portfolios and Specifications
  13.5.3 SINOVAC RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 SINOVAC Main Business Overview
  13.5.5 SINOVAC Latest Developments
13.6 Moderna
  13.6.1 Moderna Company Information
  13.6.2 Moderna RSV mRNA Vaccine Product Portfolios and Specifications
  13.6.3 Moderna RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Moderna Main Business Overview
  13.6.5 Moderna Latest Developments
13.7 GSK
  13.7.1 GSK Company Information
  13.7.2 GSK RSV mRNA Vaccine Product Portfolios and Specifications
  13.7.3 GSK RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 GSK Main Business Overview
  13.7.5 GSK Latest Developments
13.8 Pfizer
  13.8.1 Pfizer Company Information
  13.8.2 Pfizer RSV mRNA Vaccine Product Portfolios and Specifications
  13.8.3 Pfizer RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Pfizer Main Business Overview
  13.8.5 Pfizer Latest Developments
13.9 Sanofi
  13.9.1 Sanofi Company Information
  13.9.2 Sanofi RSV mRNA Vaccine Product Portfolios and Specifications
  13.9.3 Sanofi RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Sanofi Main Business Overview
  13.9.5 Sanofi Latest Developments
13.10 Nanoribo
  13.10.1 Nanoribo Company Information
  13.10.2 Nanoribo RSV mRNA Vaccine Product Portfolios and Specifications
  13.10.3 Nanoribo RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Nanoribo Main Business Overview
  13.10.5 Nanoribo Latest Developments
13.11 Immorna
  13.11.1 Immorna Company Information
  13.11.2 Immorna RSV mRNA Vaccine Product Portfolios and Specifications
  13.11.3 Immorna RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Immorna Main Business Overview
  13.11.5 Immorna Latest Developments
13.12 AIM Vaccine
  13.12.1 AIM Vaccine Company Information
  13.12.2 AIM Vaccine RSV mRNA Vaccine Product Portfolios and Specifications
  13.12.3 AIM Vaccine RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 AIM Vaccine Main Business Overview
  13.12.5 AIM Vaccine Latest Developments
13.13 Shijiazhuang Pharma Group
  13.13.1 Shijiazhuang Pharma Group Company Information
  13.13.2 Shijiazhuang Pharma Group RSV mRNA Vaccine Product Portfolios and Specifications
  13.13.3 Shijiazhuang Pharma Group RSV mRNA Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Shijiazhuang Pharma Group Main Business Overview
  13.13.5 Shijiazhuang Pharma Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. RSV mRNA Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. RSV mRNA Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Base Modification Technology
Table 4. Major Players of m1? Modification Technology
Table 5. Global RSV mRNA Vaccine Sales by Type (2020-2025) & (Units)
Table 6. Global RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Table 7. Global RSV mRNA Vaccine Revenue by Type (2020-2025) & ($ million)
Table 8. Global RSV mRNA Vaccine Revenue Market Share by Type (2020-2025)
Table 9. Global RSV mRNA Vaccine Sale Price by Type (2020-2025) & (US$/Unit)
Table 10. Global RSV mRNA Vaccine Sale by Application (2020-2025) & (Units)
Table 11. Global RSV mRNA Vaccine Sale Market Share by Application (2020-2025)
Table 12. Global RSV mRNA Vaccine Revenue by Application (2020-2025) & ($ million)
Table 13. Global RSV mRNA Vaccine Revenue Market Share by Application (2020-2025)
Table 14. Global RSV mRNA Vaccine Sale Price by Application (2020-2025) & (US$/Unit)
Table 15. Global RSV mRNA Vaccine Sales by Company (2020-2025) & (Units)
Table 16. Global RSV mRNA Vaccine Sales Market Share by Company (2020-2025)
Table 17. Global RSV mRNA Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global RSV mRNA Vaccine Revenue Market Share by Company (2020-2025)
Table 19. Global RSV mRNA Vaccine Sale Price by Company (2020-2025) & (US$/Unit)
Table 20. Key Manufacturers RSV mRNA Vaccine Producing Area Distribution and Sales Area
Table 21. Players RSV mRNA Vaccine Products Offered
Table 22. RSV mRNA Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global RSV mRNA Vaccine Sales by Geographic Region (2020-2025) & (Units)
Table 26. Global RSV mRNA Vaccine Sales Market Share Geographic Region (2020-2025)
Table 27. Global RSV mRNA Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global RSV mRNA Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global RSV mRNA Vaccine Sales by Country/Region (2020-2025) & (Units)
Table 30. Global RSV mRNA Vaccine Sales Market Share by Country/Region (2020-2025)
Table 31. Global RSV mRNA Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global RSV mRNA Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)
Table 34. Americas RSV mRNA Vaccine Sales Market Share by Country (2020-2025)
Table 35. Americas RSV mRNA Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas RSV mRNA Vaccine Sales by Type (2020-2025) & (Units)
Table 37. Americas RSV mRNA Vaccine Sales by Application (2020-2025) & (Units)
Table 38. APAC RSV mRNA Vaccine Sales by Region (2020-2025) & (Units)
Table 39. APAC RSV mRNA Vaccine Sales Market Share by Region (2020-2025)
Table 40. APAC RSV mRNA Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC RSV mRNA Vaccine Sales by Type (2020-2025) & (Units)
Table 42. APAC RSV mRNA Vaccine Sales by Application (2020-2025) & (Units)
Table 43. Europe RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)
Table 44. Europe RSV mRNA Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe RSV mRNA Vaccine Sales by Type (2020-2025) & (Units)
Table 46. Europe RSV mRNA Vaccine Sales by Application (2020-2025) & (Units)
Table 47. Middle East & Africa RSV mRNA Vaccine Sales by Country (2020-2025) & (Units)
Table 48. Middle East & Africa RSV mRNA Vaccine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa RSV mRNA Vaccine Sales by Type (2020-2025) & (Units)
Table 50. Middle East & Africa RSV mRNA Vaccine Sales by Application (2020-2025) & (Units)
Table 51. Key Market Drivers & Growth Opportunities of RSV mRNA Vaccine
Table 52. Key Market Challenges & Risks of RSV mRNA Vaccine
Table 53. Key Industry Trends of RSV mRNA Vaccine
Table 54. RSV mRNA Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. RSV mRNA Vaccine Distributors List
Table 57. RSV mRNA Vaccine Customer List
Table 58. Global RSV mRNA Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 59. Global RSV mRNA Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas RSV mRNA Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 61. Americas RSV mRNA Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC RSV mRNA Vaccine Sales Forecast by Region (2026-2031) & (Units)
Table 63. APAC RSV mRNA Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe RSV mRNA Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 65. Europe RSV mRNA Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa RSV mRNA Vaccine Sales Forecast by Country (2026-2031) & (Units)
Table 67. Middle East & Africa RSV mRNA Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global RSV mRNA Vaccine Sales Forecast by Type (2026-2031) & (Units)
Table 69. Global RSV mRNA Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global RSV mRNA Vaccine Sales Forecast by Application (2026-2031) & (Units)
Table 71. Global RSV mRNA Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abogen Bio Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Abogen Bio RSV mRNA Vaccine Product Portfolios and Specifications
Table 74. Abogen Bio RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Abogen Bio Main Business
Table 76. Abogen Bio Latest Developments
Table 77. Innorna Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Innorna RSV mRNA Vaccine Product Portfolios and Specifications
Table 79. Innorna RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Innorna Main Business
Table 81. Innorna Latest Developments
Table 82. Starna Therapeutics Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Starna Therapeutics RSV mRNA Vaccine Product Portfolios and Specifications
Table 84. Starna Therapeutics RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Starna Therapeutics Main Business
Table 86. Starna Therapeutics Latest Developments
Table 87. Hualan Biological Engineering Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Hualan Biological Engineering RSV mRNA Vaccine Product Portfolios and Specifications
Table 89. Hualan Biological Engineering RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Hualan Biological Engineering Main Business
Table 91. Hualan Biological Engineering Latest Developments
Table 92. SINOVAC Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. SINOVAC RSV mRNA Vaccine Product Portfolios and Specifications
Table 94. SINOVAC RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. SINOVAC Main Business
Table 96. SINOVAC Latest Developments
Table 97. Moderna Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Moderna RSV mRNA Vaccine Product Portfolios and Specifications
Table 99. Moderna RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Moderna Main Business
Table 101. Moderna Latest Developments
Table 102. GSK Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. GSK RSV mRNA Vaccine Product Portfolios and Specifications
Table 104. GSK RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. GSK Main Business
Table 106. GSK Latest Developments
Table 107. Pfizer Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer RSV mRNA Vaccine Product Portfolios and Specifications
Table 109. Pfizer RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Sanofi Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Sanofi RSV mRNA Vaccine Product Portfolios and Specifications
Table 114. Sanofi RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Sanofi Main Business
Table 116. Sanofi Latest Developments
Table 117. Nanoribo Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Nanoribo RSV mRNA Vaccine Product Portfolios and Specifications
Table 119. Nanoribo RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Nanoribo Main Business
Table 121. Nanoribo Latest Developments
Table 122. Immorna Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Immorna RSV mRNA Vaccine Product Portfolios and Specifications
Table 124. Immorna RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 125. Immorna Main Business
Table 126. Immorna Latest Developments
Table 127. AIM Vaccine Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. AIM Vaccine RSV mRNA Vaccine Product Portfolios and Specifications
Table 129. AIM Vaccine RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 130. AIM Vaccine Main Business
Table 131. AIM Vaccine Latest Developments
Table 132. Shijiazhuang Pharma Group Basic Information, RSV mRNA Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. Shijiazhuang Pharma Group RSV mRNA Vaccine Product Portfolios and Specifications
Table 134. Shijiazhuang Pharma Group RSV mRNA Vaccine Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 135. Shijiazhuang Pharma Group Main Business
Table 136. Shijiazhuang Pharma Group Latest Developments

LIST OF FIGURES

Figure 1. Picture of RSV mRNA Vaccine
Figure 2. RSV mRNA Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RSV mRNA Vaccine Sales Growth Rate 2020-2031 (Units)
Figure 7. Global RSV mRNA Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. RSV mRNA Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. RSV mRNA Vaccine Sales Market Share by Country/Region (2024)
Figure 10. RSV mRNA Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Base Modification Technology
Figure 12. Product Picture of m1? Modification Technology
Figure 13. Global RSV mRNA Vaccine Sales Market Share by Type in 2025
Figure 14. Global RSV mRNA Vaccine Revenue Market Share by Type (2020-2025)
Figure 15. RSV mRNA Vaccine Consumed in Hospital
Figure 16. Global RSV mRNA Vaccine Market: Hospital (2020-2025) & (Units)
Figure 17. RSV mRNA Vaccine Consumed in Clinic
Figure 18. Global RSV mRNA Vaccine Market: Clinic (2020-2025) & (Units)
Figure 19. RSV mRNA Vaccine Consumed in Others
Figure 20. Global RSV mRNA Vaccine Market: Others (2020-2025) & (Units)
Figure 21. Global RSV mRNA Vaccine Sale Market Share by Application (2024)
Figure 22. Global RSV mRNA Vaccine Revenue Market Share by Application in 2025
Figure 23. RSV mRNA Vaccine Sales by Company in 2025 (Units)
Figure 24. Global RSV mRNA Vaccine Sales Market Share by Company in 2025
Figure 25. RSV mRNA Vaccine Revenue by Company in 2025 ($ millions)
Figure 26. Global RSV mRNA Vaccine Revenue Market Share by Company in 2025
Figure 27. Global RSV mRNA Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global RSV mRNA Vaccine Revenue Market Share by Geographic Region in 2025
Figure 29. Americas RSV mRNA Vaccine Sales 2020-2025 (Units)
Figure 30. Americas RSV mRNA Vaccine Revenue 2020-2025 ($ millions)
Figure 31. APAC RSV mRNA Vaccine Sales 2020-2025 (Units)
Figure 32. APAC RSV mRNA Vaccine Revenue 2020-2025 ($ millions)
Figure 33. Europe RSV mRNA Vaccine Sales 2020-2025 (Units)
Figure 34. Europe RSV mRNA Vaccine Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa RSV mRNA Vaccine Sales 2020-2025 (Units)
Figure 36. Middle East & Africa RSV mRNA Vaccine Revenue 2020-2025 ($ millions)
Figure 37. Americas RSV mRNA Vaccine Sales Market Share by Country in 2025
Figure 38. Americas RSV mRNA Vaccine Revenue Market Share by Country (2020-2025)
Figure 39. Americas RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Figure 40. Americas RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 41. United States RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC RSV mRNA Vaccine Sales Market Share by Region in 2025
Figure 46. APAC RSV mRNA Vaccine Revenue Market Share by Region (2020-2025)
Figure 47. APAC RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Figure 48. APAC RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 49. China RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. India RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe RSV mRNA Vaccine Sales Market Share by Country in 2025
Figure 57. Europe RSV mRNA Vaccine Revenue Market Share by Country (2020-2025)
Figure 58. Europe RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Figure 59. Europe RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 60. Germany RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 61. France RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. UK RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa RSV mRNA Vaccine Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa RSV mRNA Vaccine Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa RSV mRNA Vaccine Sales Market Share by Application (2020-2025)
Figure 68. Egypt RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries RSV mRNA Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of RSV mRNA Vaccine in 2025
Figure 74. Manufacturing Process Analysis of RSV mRNA Vaccine
Figure 75. Industry Chain Structure of RSV mRNA Vaccine
Figure 76. Channels of Distribution
Figure 77. Global RSV mRNA Vaccine Sales Market Forecast by Region (2026-2031)
Figure 78. Global RSV mRNA Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global RSV mRNA Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global RSV mRNA Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global RSV mRNA Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global RSV mRNA Vaccine Revenue Market Share Forecast by Application (2026-2031)